MWA
GILD icon

Meridian Wealth Advisors’s Gilead Sciences GILD Stock Holding History

Meridian Wealth Advisors’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$266K Sell
2,107
-7
-0.3% -$922 0.03% 182
2026
Q1 		$295K Buy
2,114
+57
+3% +$7.98K 0.04% 164
2025
Q4 		$253K Sell
2,057
-54
-3% -$6.56K 0.04% 165
2025
Q3 		$234K Buy
2,111
+66
+3% +$7.5K 0.03% 169
2025
Q2 		$227K Buy
2,045
+7
+0.3% +$745 0.04% 167
2025
Q1 		$228K Buy
+2,038
New +$210K 0.04% 159
2019
Q1 		– Sell
-1,035
Closed -$65K – 235
2018
Q4 		$65K Buy
+1,035
New +$72.3K 0.05% 217

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Meridian Wealth Advisors's GILD Position: Q2 2026 in Review

Meridian Wealth Advisors reduced its Gilead Sciences (GILD) stake by 0.33% in Q2 2026, selling an estimated $922 and leaving 2,107 shares worth $266K. The position accounts for 0.03% of the portfolio, ranked #182.

Meridian Wealth Advisors first reported a position in GILD in Q4 2018 and has held it in 7 quarters since. The position peaked at $295K in Q1 2026. 2,268 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Meridian Wealth Advisors held 2,107 shares of Gilead Sciences worth $266K as of Q2 2026.
  • Meridian Wealth Advisors sold 7 Gilead Sciences shares in Q2 2026, an estimated $922.
  • Gilead Sciences made up 0.03% of Meridian Wealth Advisors's portfolio in Q2 2026, its #182 holding.
  • Meridian Wealth Advisors first reported a position in Gilead Sciences in Q4 2018 and has held it in 7 quarters since.
  • Meridian Wealth Advisors's Gilead Sciences position peaked at $295K in Q1 2026.
  • 2,268 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Meridian Wealth Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.